Paper28463501
Hyaluronan Nanoparticles Selectively Target Plaque-Associated Macrophages and Improve Plaque Stability in Atherosclerosis.
Beldman TJ and 21 others. ACS Nano, 2017. Cited by 141 papers, by iCite.
Cite this record
ConductScience Library. Hyaluronan Nanoparticles Selectively Target Plaque-Associated Macrophages and Improve Plaque Stability in Atherosclerosis. Papers, record 28463501. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28463501
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Inflammatory Agents | Major topic |
| Atherosclerosis | Major topic |
| Hyaluronic Acid | Major topic |
| Macrophages | Major topic |
| Nanoparticles | Major topic |
| Plaque, Atherosclerotic | Major topic |
| Animals | |
| Male | |
| Mice | |
| Positron-Emission Tomography | |
| Rabbits | |
| Tissue Distribution |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 HL125703 | NHLBI NIH HHS | United States | R01HL125703 | PubMed and NIH | NIH RePORTER |
| P01 HL131478 | NHLBI NIH HHS | United States | P01HL131478 | PubMed and NIH | NIH RePORTER |
| P30 CA008748 | NCI NIH HHS | United States | P30CA008748 | PubMed and NIH | NIH RePORTER |
| R01 EB009638 | NIBIB NIH HHS | United States | R01EB009638 | PubMed and NIH | NIH RePORTER |
| R01 HL118440 | NHLBI NIH HHS | United States | R01HL118440 | PubMed and NIH | NIH RePORTER |
References79
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15229478 | Hyaluronan: from extracellular glue to pericellular cue. | Nat Rev Cancer | 2004 | https://conductscience.org/library/papers/15229478 | PubMed |
| 2 | 20008845 | Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities. | Clin Cancer Res | 2009 | https://conductscience.org/library/papers/20008845 | PubMed |
| 3 | 12194965 | Angiogenic oligosaccharides of hyaluronan induce multiple signaling pathways affecting vascular endothelial cell mitogenic and wound healing responses. | J Biol Chem | 2002 | https://conductscience.org/library/papers/12194965 | PubMed |
| 4 | 22592627 | Dual role of lipoproteins in endothelial cell dysfunction in atherosclerosis. | Cell Tissue Res | 2012 | https://conductscience.org/library/papers/22592627 | PubMed |
| 5 | 15705963 | Overexpression of hyaluronan in the tunica media promotes the development of atherosclerosis. | Circ Res | 2005 | https://conductscience.org/library/papers/15705963 | PubMed |
| 6 | 11853916 | Targeting to macrophages: role of physicochemical properties of particulate carriers--liposomes and microspheres--on the phagocytosis by macrophages. | J Control Release | 2002 | https://conductscience.org/library/papers/11853916 | PubMed |
| 7 | 21394792 | Hyaluronic acid hydrogels for biomedical applications. | Adv Mater | 2011 | https://conductscience.org/library/papers/21394792 | PubMed |
| 8 | 18758474 | Nanoparticle therapeutics: an emerging treatment modality for cancer. | Nat Rev Drug Discov | 2008 | https://conductscience.org/library/papers/18758474 | PubMed |
| 9 | 21967065 | Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy. | ACS Nano | 2011 | https://conductscience.org/library/papers/21967065 | PubMed |
| 10 | 25619964 | Atherosclerotic plaque targeting mechanism of long-circulating nanoparticles established by multimodal imaging. | ACS Nano | 2015 | https://conductscience.org/library/papers/25619964 | PubMed |
| 11 | 26295063 | Inhibiting macrophage proliferation suppresses atherosclerotic plaque inflammation. | Sci Adv | 2015 | https://conductscience.org/library/papers/26295063 | PubMed |
| 12 | 24653726 | Hyaluronan, a crucial regulator of inflammation. | Front Immunol | 2014 | https://conductscience.org/library/papers/24653726 | PubMed |
| 13 | 2180732 | Binding of hyaluronic acid to lymphoid cell lines is inhibited by monoclonal antibodies against Pgp-1. | Exp Cell Res | 1990 | https://conductscience.org/library/papers/2180732 | PubMed |
| 14 | 11717318 | Hyaluronan-cell interactions in cancer and vascular disease. | J Biol Chem | 2002 | https://conductscience.org/library/papers/11717318 | PubMed |
| 15 | 762499 | Hyaluronidase-sensitive halos around adherent cells. Their role in blocking lymphocyte-mediated cytolysis. | J Exp Med | 1979 | https://conductscience.org/library/papers/762499 | PubMed |
| 16 | 22693353 | Metronomic activity of CD44-targeted hyaluronic acid-paclitaxel in ovarian carcinoma. | Clin Cancer Res | 2012 | https://conductscience.org/library/papers/22693353 | PubMed |
| 17 | 20202637 | FDG-PET imaging of atherosclerosis: Do we know what we see? | Atherosclerosis | 2010 | https://conductscience.org/library/papers/20202637 | PubMed |
| 18 | 24445279 | A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation. | Nat Commun | 2014 | https://conductscience.org/library/papers/24445279 | PubMed |
| 19 | 20977242 | Hyaluronic acid immobilized magnetic nanoparticles for active targeting and imaging of macrophages. | Bioconjug Chem | 2010 | https://conductscience.org/library/papers/20977242 | PubMed |
| 20 | 17617562 | Cutting edge: high molecular weight hyaluronan promotes the suppressive effects of CD4+CD25+ regulatory T cells. | J Immunol | 2007 | https://conductscience.org/library/papers/17617562 | PubMed |
Cited by80
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 141 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42909384 | Atherosclerosis nanotheranostics: a perspective from macrophages. | Theranostics | 2026 | https://conductscience.org/library/papers/42909384 | PubMed |
| 42254054 | Polymeric Nanomaterials for Atherosclerosis Diagnosis and Treatment. | Polym Sci Technol | 2025 | https://conductscience.org/library/papers/42254054 | PubMed |
| 42108479 | Nootkatone confers MAOB-dependent neuroprotection against ferroptotic injury via brain-targeted nanoparticle delivery in ischemic stroke. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/42108479 | PubMed |
| 42094740 | How Advanced is Nanomedicine to Treat Atherosclerosis? A Comprehensive Review of the Literature. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42094740 | PubMed |
| 41783546 | Nanozyme-Based Anti-Inflammatory Strategies in Cardiovascular Disease Management: Clinical Prospects and Challenges. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/41783546 | PubMed |
| 41702598 | Macrophages in human atherosclerotic plaques in the era of single-cell and spatial transcriptomics. | Immunohorizons | 2026 | https://conductscience.org/library/papers/41702598 | PubMed |
| 41012478 | A New Approach to the Diagnosis and Treatment of Cardiovascular Diseases. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/41012478 | PubMed |
| 40717066 | Nanomedicine in cardiovascular and cerebrovascular diseases: targeted nanozyme therapies and their clinical potential and current challenges. | J Nanobiotechnology | 2025 | https://conductscience.org/library/papers/40717066 | PubMed |
| 40110293 | Essential information about nanotechnology in cardiology. | Ann Med Surg (Lond) | 2025 | https://conductscience.org/library/papers/40110293 | PubMed |
| 39917718 | Nanosystems for modulation of immune responses in periodontal therapy: a mini-review. | Front Dent Med | 2024 | https://conductscience.org/library/papers/39917718 | PubMed |
| 39752488 | Deciphering neutrophil dynamics: Enhanced phagocytosis of elastic particles and impact on vascular-targeted carrier performance. | Sci Adv | 2025 | https://conductscience.org/library/papers/39752488 | PubMed |
| 39743560 | Extracellular matrix in vascular homeostasis and disease. | Nat Rev Cardiol | 2025 | https://conductscience.org/library/papers/39743560 | PubMed |
| 39513306 | Stimuli-responsive Nano/Biomaterials for Smart Drug Delivery in Cardiovascular Diseases: Promises, Challenges and Outlooks. | Curr Med Chem | 2025 | https://conductscience.org/library/papers/39513306 | PubMed |
| 39239513 | Molecular imaging nanoprobes and their applications in atherosclerosis diagnosis. | Theranostics | 2024 | https://conductscience.org/library/papers/39239513 | PubMed |
| 39185808 | Dual-Function Nanoscale Coordination Polymer Nanoparticles for Targeted Diagnosis and Therapeutic Delivery in Atherosclerosis. | Small | 2024 | https://conductscience.org/library/papers/39185808 | PubMed |
| 38943654 | Hyaluronic Acid Nanoparticles with Parameters Required for In Vivo Applications: From Synthesis to Parametrization. | Biomacromolecules | 2024 | https://conductscience.org/library/papers/38943654 | PubMed |
| 38930939 | Nanoparticles as Drug Delivery Systems for the Targeted Treatment of Atherosclerosis. | Molecules | 2024 | https://conductscience.org/library/papers/38930939 | PubMed |
| 38794614 | Organic Nanoparticles in Progressing Cardiovascular Disease Treatment and Diagnosis. | Polymers (Basel) | 2024 | https://conductscience.org/library/papers/38794614 | PubMed |
| 38696700 | Targeting macrophages with multifunctional nanoparticles to detect and prevent atherosclerotic cardiovascular disease. | Cardiovasc Res | 2024 | https://conductscience.org/library/papers/38696700 | PubMed |
| 38672722 | Endovascular Drug Delivery. | Life (Basel) | 2024 | https://conductscience.org/library/papers/38672722 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD44 | 960 | PubTator's text mining | https://conductscience.org/library/genes/960 | NCBI Gene |
| HMMR | 3161 | PubTator's text mining | https://conductscience.org/library/genes/3161 | NCBI Gene |
| ICAM1 | 3383 | PubTator's text mining | https://conductscience.org/library/genes/3383 | NCBI Gene |
| LYVE1 | 10894 | PubTator's text mining | https://conductscience.org/library/genes/10894 | NCBI Gene |
| TLR4 | 7099 | PubTator's text mining | https://conductscience.org/library/genes/7099 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28463501
GET https://conductscience.org/api/papers/v1/28463501/authors?page=2